Nuvation Bio Inc. (NUVB)
$6.65-$0.34 (-4.86%) Today
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 25,000 | $118K |
| Open-market sale | 4 | 335,668 | $2.13M |
| Option exercise | 14 | 751,336 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
38 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gary Hattersley - Officer | Option exercise | Class A Common Stock | 100,000 | $1.87 | $187K | |
| Gary Hattersley - Officer | Open-market sale | Class A Common Stock | 100,000 | $7.09 | $709K | |
| Gary Hattersley - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Philippe Sauvage - Officer | Option exercise | Class A Common Stock | 39,999 | $2.17 | $87K | |
| Philippe Sauvage - Officer | Option exercise | Class A Common Stock | 1 | $1.97 | $2 | |
| Philippe Sauvage - Officer | Option exercise | Stock Option (Right to Buy) | 39,999 | $0.00 | - | |
| Philippe Sauvage - Officer | Option exercise | Stock Option (Right to Buy) | 1 | $0.00 | - | |
| Stacy Markel - Officer | Option exercise | Class A Common Stock | 90,380 | $1.87 | $169K | |
| Stacy Markel - Officer | Option exercise | Class A Common Stock | 34,620 | $1.74 | $60K | |
| Stacy Markel - Officer | Open-market sale | Class A Common Stock | 125,000 | $6.03 | $753K | |
| Stacy Markel - Officer | Option exercise | Stock Option (Right to Buy) | 90,380 | $0.00 | - | |
| Stacy Markel - Officer | Option exercise | Stock Option (Right to Buy) | 34,620 | $0.00 | - | |
| Kerry Wentworth - Officer | Option exercise | Class A Common Stock | 63,000 | $2.93 | $185K | |
| Kerry Wentworth - Officer | Open-market sale | Class A Common Stock | 63,000 | $6.02 | $379K | |
| Kerry Wentworth - Officer | Option exercise | Stock Option (Right to Buy) | 63,000 | $0.00 | - | |
| Philippe Sauvage - Officer | Option exercise | Class A Common Stock | 47,668 | $2.17 | $103K | |
| Philippe Sauvage - Officer | Open-market sale | Class A Common Stock | 47,668 | $6.01 | $286K | |
| Philippe Sauvage - Officer | Option exercise | Stock Option (Right to Buy) | 47,668 | $0.00 | - | |
| Robert Mashal | Open-market purchase | Class A Common Stock | 25,000 | $4.73 | $118K | |
| W. Anthony Vernon | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Robert Mashal | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Kathryn E. Falberg | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Kim D. Blickenstaff | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Robert B. Bazemore | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Xiangmin Cui | Grant or award | Stock Option (Right to Buy) | 123,397 | $0.00 | - | |
| Kerry Wentworth - Officer | Option exercise | Class A Common Stock | 36,750 | $2.93 | $108K | |
| Kerry Wentworth - Officer | Open-market sale | Class A Common Stock | 36,750 | $5.01 | $184K | |
| Kerry Wentworth - Officer | Option exercise | Stock Option (Right to Buy) | 36,750 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 50,000 | $1.94 | $97K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 50,000 | $5.02 | $251K | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Kerry Wentworth - Officer | Option exercise | Class A Common Stock | 100,000 | $1.87 | $187K | |
| Kerry Wentworth - Officer | Option exercise | Class A Common Stock | 100,000 | $1.94 | $194K | |
| Kerry Wentworth - Officer | Open-market sale | Class A Common Stock | 200,000 | $4.52 | $904K | |
| Kerry Wentworth - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Kerry Wentworth - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Dongfang Liu - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
| Moses Makunje - Officer | Grant or award | Class A Common Stock | 50,761 | $0.00 | - | |
| Moses Makunje - Officer | Grant or award | Stock Option (Right to Buy) | 224,439 | $0.00 | - | |
| Kerry Wentworth - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
 Colleen Sjogren - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
| Philippe Sauvage - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
| Stacy Markel - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
| Xiangmin Cui | Grant or award | Stock Option (Right to Buy) | 74,813 | $0.00 | - | |
| Gary Hattersley - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
| David C. Hanley - Officer | Grant or award | Stock Option (Right to Buy) | 748,130 | $0.00 | - | |
 David Hung - Officer | Grant or award | Stock Option (Right to Buy) | 1,995,012 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 150,000 | $2.93 | $440K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 150,000 | $7.82 | $1.17M | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 10,000 | $3.61 | $36K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 10,000 | $7.50 | $75K | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 10,000 | $3.61 | $36K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 10,000 | $8.00 | $80K | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 20,000 | $1.87 | $37K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 20,000 | $7.00 | $140K | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| Gary Hattersley - Officer | Option exercise | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Gary Hattersley - Officer | Option exercise | Class A Common Stock | 69,051 | $1.74 | $120K | |
| Gary Hattersley - Officer | Option exercise | Class A Common Stock | 300,000 | $1.94 | $582K | |
| Gary Hattersley - Officer | Open-market sale | Class A Common Stock | 69,051 | $7.23 | $499K | |
| Gary Hattersley - Officer | Option exercise | Stock Option (Right to Buy) | 69,051 | $0.00 | - | |
| Gary Hattersley - Officer | Open-market sale | Class A Common Stock | 300,000 | $7.23 | $2.17M | |
| David C. Hanley - Officer | Option exercise | Class A Common Stock | 200,000 | $1.87 | $374K | |
| David C. Hanley - Officer | Open-market sale | Class A Common Stock | 200,000 | $7.14 | $1.43M | |
| David C. Hanley - Officer | Option exercise | Stock Option (Right to Buy) | 200,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GARY HATTERSLEY | Officer | 100,000 | $696K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Nuvation Bio Inc. (NUVB) had 6 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for NUVB runs to 38 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of NUVB was filed in the last 90 days, totaling $118K.
4 insider sales of NUVB were filed in the last 90 days, totaling $2.13M.
This page tracks NUVB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NUVB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
